No abstract available
Keywords:
Endocrine positive breast cancer; endocrine resistance.
MeSH terms
-
Antineoplastic Agents, Hormonal / adverse effects
-
Antineoplastic Agents, Hormonal / therapeutic use*
-
Aromatase Inhibitors / adverse effects
-
Aromatase Inhibitors / therapeutic use*
-
Biomarkers, Tumor / genetics
-
Breast Neoplasms / drug therapy*
-
Breast Neoplasms / genetics
-
Breast Neoplasms / pathology
-
Drug Resistance, Neoplasm / genetics*
-
Estrogen Receptor alpha / genetics
-
Estrogen Receptor beta / genetics
-
Female
-
Humans
-
Neoplasm Metastasis
-
Postmenopause
Substances
-
Antineoplastic Agents, Hormonal
-
Aromatase Inhibitors
-
Biomarkers, Tumor
-
ESR1 protein, human
-
ESR2 protein, human
-
Estrogen Receptor alpha
-
Estrogen Receptor beta